The ‘Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration’ (DREAM) study: an open‐label phase II trial

British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-.

Source: British Journal of Clinical Pharmacology - October 20, 2018 Category: Drugs & Pharmacology Authors: Antonia M. Joussen, Sebastian Wolf, Peter K. Kaiser, David Boyer, Thomas Schmelter, Rupert Sandbrink, Oliver Zeitz, Gesa Deeg, Annett Richter, Torsten Zimmermann, Joachim Hoechel, Ulf Buetehorn, Walter Schmitt, Brigitte Stemper, Michael K. B Source Type: research